Combating drugs: transmission of designer drug samples

This procedure focuses on improving the way EU member states share samples of illegal narcotic substances, specifically 'designer drugs'. By streamlining the transmission of these samples, law enforcement agencies can more quickly identify new synthetic drugs and coordinate their response to emerging drug threats.

This affects police forces and forensic laboratories across the EU, enabling them to better detect illegal substances and disrupt the networks trafficking synthetic drugs.